Lancet Oncology

Oncology & Cancer

More chemo drugs don't improve treatment of rare bone cancer

Osteosarcoma patients with tumors that haven't responded well to the standard chemotherapy regimen have unimproved outcomes and more side effects when given two additional drugs, a large international trial has found.

Oncology & Cancer

New drug shrinks brain tumours in melanoma patients

(Medical Xpress)—Australian researchers have given hope to patients with advanced melanoma by showing that a new drug targeting a common mutation in melanoma successfully shrank tumours that had spread to the brain.

Oncology & Cancer

Study compares cancer drug cost, benefit

Queen's University researcher Christopher Booth reveals the price of new cancer therapies is not associated with treatment effectiveness.

page 10 from 39